Seeing Is Believing
Currently out of the existing stock ratings of Eric Criscuolo, 18 are a HOLD (47.37%), 1 are a SELL (2.63%), 19 are a BUY (50%).
Analyst Eric Criscuolo works with a stock forecast success ratio of 78.13% fulfilled within 144.63 days on average. Previously, Eric Criscuolo worked at MIZUHO.
Eric Criscuolo’s has documented 62 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CLVS, Clovis Oncology at 24-Aug-2016.
Analyst best performing recommendations are on XON (PRECIGEN).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 5/4/2016. The price target of $12 was fulfilled within 57 days with a profit of $6.19 (106.54%) receiving and performance score of 18.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
90
$27.93 (45.00%)
120
2 months 14 days ago
2/7 (28.57%)
$30.51 (51.29%)
39
Hold
91
$28.93 (46.61%)
4 months 4 days ago
9/10 (90%)
$17.23 (23.36%)
154
Buy
160
4 months 23 days ago
15/17 (88.24%)
$35.95 (28.98%)
158
Buy
100
$37.93 (61.11%)
85
6 months 3 days ago
1/3 (33.33%)
$32.98 (49.21%)
18
Buy
80
$17.93 (28.89%)
90
6 months 20 days ago
4/7 (57.14%)
$13.07 (19.53%)
31
What Year was the first public recommendation made by Eric Criscuolo?